Blueprint Medicines | ARS: Annual Report to Security Holders
Blueprint Medicines | DEF 14A: Definitive information statements
Blueprint Medicines | 8-K: Current report
Blueprint Medicines | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. ROWE PRICE ASSOCIATES, INC.(10.2%)
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Landsittel Michael
Blueprint Medicines | 144: Notice of proposed sale of securities pursuant to Rule 144
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Albers Jeffrey W.
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Albers Jeffrey W.
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Landsittel Michael
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Hurley Ariel
Blueprint Medicines | 144: Notice of proposed sale of securities pursuant to Rule 144
Blueprint Medicines | 144: Notice of proposed sale of securities pursuant to Rule 144
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Lee Philina
Blueprint Medicines | 144: Notice of proposed sale of securities pursuant to Rule 144
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Hewes L. Becker
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Durso-Bumpus Debra
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Haviland Kate
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Lee Philina
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Murray Christopher K.
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Landsittel Michael
No Data